CD79A and COVID-19: Liu et al. (2022) have shown that a single intranasal delivery of an attenuated SARS-CoV-2, which included a pair of mutations in Nsp1, induced both mucosal and systemic IgA and IgG-mediated protection in the Golden Syrian hamster COVID-19 model [3].